CXCR4 and glioblastoma: Furthermore, CPZ1344 inhibited U87 cell migration and angiogenesis, leading to cell cycle arrest in the G1 phase as well as inhibition of CXCR4 signaling, thereby demonstrating the antitumor effects of CPZ1344 and proposing it as a possible new treatment for glioblastoma patients [137].